MIRA INFORM REPORT

 

 

Report No. :

315929

Report Date :

02.04.2015

 

IDENTIFICATION DETAILS

 

Name :

ATUL LIMITED (w.e.f.31.07.1996)

 

 

Formerly Known As :

ATUL PRODUCTS LIMITED

 

 

Registered Office :

Atul House, G I Patel Marg, Ahmedabad – 380014, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

11.12.1975

 

 

Com. Reg. No.:

04-002859

 

 

Capital Investment / Paid-up Capital :

Rs.296.800 Million

 

 

CIN No.:

[Company Identification No.]

L99999GJ1975PLC002859

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Dyestuff Chemicals, Drugs and Pharmaceuticals.

 

 

No. of Employees :

2761 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (63)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 27000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well-established company having fine track record.

 

The company’s products are well received in the market. Overall fundamentals are good.

 

The rating also takes into consideration decent profit margins and good networth position of the company.

 

Trade relations are fair. Business is active. Payment terms are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE Rating

Rating

Long term Bank facilities = AA+

Rating Explanation

Having high degree of safety and carry very low credit risk.

Date

November 25, 2014

 

 

Rating Agency Name

CARE Rating

Rating

Short term Bank facilities = A1+

Rating Explanation

Having strong degree of safety and carry lowest credit risk.

Date

November 25, 2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DENIED

 

MANAGEMENT NON CO-OPERATIVE

 

CONTACT NO.: 91-22-39876000

 

 

LOCATIONS

 

Registered Office :

Atul House, G I Patel Marg, Ahmedabad – 380014, Gujarat, India

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

wk.ag@atul.co.in

wk.ar@atul.co.in

wk.cl@atul.co.in

fi@atul.co.in

sec@atul.co.in

ahd@atul.co.in

jayesh_desai@atul.co.in

nirali_solanki@atul.co.in

Website :

http://www.atul.co.in

 

 

Head Office :

Colours Division Post Atul, Valsad – 396020, Gujarat, India

Tel. No.:

91-2632-233261/ 5

Fax No.:

91-2632-233619/ 233375/ 233024/ 233619/ 233384

E-Mail :

sec@atul.co.in

 

 

Mumbai Office :

310 B, Veer Savarkar Marg, Adjacent to Prabhadevi Telephone Exchange, Opposite India United Mills, Prabhadevi, Dadar (West), Mumbai-400028, Maharashtra, India

Tel. No.:

91-22-39876000

Fax No.:

91-22-24376061/ 24386065

E-Mail :

mum@atul.co.in

 

 

Factory 1 :

297, GIDC Industrial Estate,  Ankleshwar - 393002, Gujarat, India

 

 

Factory 2 :

Atul, District Valsad - 396020, Gujarat, India

 

 

Factory 3 :

MIDC, Tarapur, Thane - 401506, Maharashtra, India

 

 

Factory 4 :

GIDC, Kharod, District Bharuch - 394115, Gujarat, India

 

 

DIRECTORS

 

AS ON 31.03.2014

 

Name :

Mr. S S Lalbhai

Designation :

Chairman and Managing Director

 

 

Name :

Mr. S A Lalbhai

Designation :

Managing Director

 

 

Name :

Mr. G S Patel

Designation :

Independent Director

Date of Birth/ Age :

16.11.1923

Brief Resume :

Mr. G S Patel is a Director of the Company since August 10, 1983.

Mr. Patel was the Chairman of Unit Trust of India. Previously he held directorships in 20 other companies in public and private sectors.

Mr. Patel holds BSc (Economics) degree from London School of Economics, Bar-at-Law degree from Lincoln’s Inn and MA (Economics) and LLB degrees from the University of Mumbai.

 

 

Name :

Dr. S S Baijal

Designation :

Independent Director

Date of Birth/ Age :

06.09.1929

Brief Resume :

Dr. S S Baijal is a Director of the Company since June 13, 1984.

Dr. Baijal was a Lecturer in Organic Chemistry, Lucknow University. He was a Whole-time Director and CEO of Atic Industries Limited, Managing Director of IEL Limited and Chairman and CEO of ICI companies in India.

Dr. Baijal holds PhD degree in Chemistry from the University of Allahabad.

Directorship in other companies :

Public Companies:

·         BMG Enterprises Limited

·         CAE Rossell India Limited

·         DCM Shriram Credit and Investments Limited

·         DCM Shriram Limited

·         Rossell Tea Limited

 

Private Companies:

·         Delhi Guest Houses Private Limited

 

 

Name :

Mr. B S Mehta

Designation :

Independent Director

Date of Birth/ Age :

19.09.1935

Brief Resume :

Mr. B S Mehta is a Director of the Company since April 16, 1992.

Mr. Mehta is a Practicing Chartered Accountant and is a Chief Mentor of B S Mehta and Co. He is a past President of The Institute of Chartered Accountants of India. He was involved in educational activities at the graduate and post graduate levels in the University of Mumbai.

Mr. Mehta holds B Com (Hons) degree from the University of Mumbai and is a Fellow Member of The Institute of Chartered Accountants of India.

Directorship in other companies :

Public Companies:

·         Bharat Bijlee Limited

·         Ceat Limited

·         Century Enka Limited

·         Gillette India Limited

·         Housing Development Finance Corporation Limited

·         IL and FS Investment Managers Limited

·         J B Chemicals and Pharmaceuticals Limited

·         Jumbo World Holdings Limited (Body Incorporated outside India)

·         NSDL e-Governance Infrastructure Limited

·         Pidilite Industries Limited

·         Proctor and Gamble Hygiene and Health Care Limited

·         Sasken Communication Technologies Limited

·         SBI Capital Markets Limited

·         Sudarshan Chemical Industries Limited

 

Private Companies:

·         Uhde India Private Limited

 

 

Name :

Mr. H S Shah

Designation :

Independent Director

Date of Birth/ Age :

01.10.1934

Brief Resume :

Mr. H S Shah is a Director of the Company since October 21, 1992.

Mr. Shah held several senior and top positions in the Government of India and other academic | research, commercial and social organisations.

Mr. Shah holds MA degree in Sociology from Gujarat University and has passed Indian Administrative Service examination conducted by Union Public Service Commission.

 

Companies:

Chairman, Gujarat Industrial Investment Corporation

Chairman and Managing Director, Indian Petrochemicals Corporation Limited

Vice Chairman, GE Capital (India) Limited

 

Academic | Research:

Chairman, Darshak Itihas Nidhi

Chairman, Gujarat Ecology Society

Chairman, Gujarat Industrial Research and Development Agency

Chairman, National Institute of Design

Founder Chairman, Gujarat Institute of Desert Ecology

Member, Board of Governors of IIT, Mumbai

President, Charutar Arogya Mandal (Medical College and Hospital)

 

Social:

Chairman, Gujarat Rural Institute for Socio Economic Reconstruction Vadodara

Chairman, Kachnar Trust

Founder President and Member, Heritage Trust

Founder Trustee, Indian Trust for Rural Heritage and Development

Life Trustee, BAIF Development Research Foundation

 

Government:

Chairman, Gujarat Ecology Commission

Joint Director, Bureau of Public Enterprises, Government of India

Joint Secretary to the Prime Minister, Government of India

Member, Central Pollution Control Board

Secretary, Posts and Telegraph Board of India

 

Others:

Chairman, Vikram A Sarabhai Community Science Centre

Life Trustee and Member, Gujarat Nature Conservation Society

Trustee, Shram Mandir

Directorship in other companies :

Public Companies:

·         Sun Pharmaceutical Industries Limited

·         Supreme Petrochem Limited

 

Private Companies:

·         Flexican Bellows Private Limited

 

 

Name :

Mr. S M Datta

Designation :

Independent Director

Date of Birth/ Age :

01.07.1936

Brief Resume :

Mr. S M Datta is a Director of the Company since October 28, 2002.

Mr. Datta is the Chairman of Administrative Staff College of India. He is also associated with various other renowned institutes.

Mr. Datta was the Chairman of Hindustan Unilever Limited as well as of all Unilever Group companies in India and Nepal from 1990 to 1996.

Mr. Datta is a Chartered Engineer; Honorary Fellow - All India Management Association, Fellow - Indian Institute of Chemical Engineers, Member - Society of Chemical Industry (London) and Fellow - The Institution of Engineers (India).

Mr. Datta holds a post graduate degree in Science and Technology from the University of Calcutta.

Directorship in other companies :

Public Companies:

·         Bhoruka Power Corporation Limited

·         Castrol India Limited - Chairman

·         Door Sabha Nigam Limited

·         ILandFS Investment Managers Limited - Chairman

·         Peerless Financial Products Distributors’ Limited - Chairman

·         Peerless General Finance and Investment Company Limited

·         Peerless Hotels Limited

·         Philips Electronics India Limited - Chairman

·         Rabo India Finance Limited

·         Speciality Restaurants Limited - Chairman

·         Transport Corporation of India Limited - Chairman

·         Zodiac Clothing Company Limited

 

Private Companies:

·         Chandras Chemical Enterprises Private Limited

·         SMD Management Consultants Private Limited

 

 

Name :

Mr. V S Rangan

Designation :

Independent Director

Date of Birth/ Age :

13.02.1960

Brief Resume :

Mr. V S Rangan is a Director of the Company since July 19, 2010.

Mr. Rangan is an Executive Director of Housing Development Finance Corporation Limited.

Mr. Rangan is an Associate of The Institute of Chartered Accountants of India and The Institute of Cost and Works Accountants of India.

Directorship in other companies :

Public Companies:

·         Cholamandalam Investment and Finance Company Limited

·         HDFC Developers Limited

·         HDFC Holdings Limited

·         HDFC Investments Limited

·         HDFC Property Ventures Limited

·         HDFC Trustee Company Limited

·         HDFC Venture Capital Limited

·         Hindustan Oil Exploration Company Limited

·         Housing Development Finance Corporation Limited

·         TVS Credit Services Limited

 

Private Companies:

·         Credila Financial Services Private Limited

·         HDFC Education and Development Services Private Limited

·         IVF Advisors Private Limited

·         Ruralshores Business Services Private Limited

 

 

Name :

Mr. R A Shah

Designation :

Independent Director

 

 

Name :

Mr. B N Mohanan

Designation :

Whole-time Director

Date of Birth/ Age :

26.05.1950

Brief Resume :

Mr. B N Mohanan is a Whole-time Director of the Company since January 01, 2009. He joined the Company in 1992.

Mr. Mohanan has over 4 decades of professional experience in various capacities. Currently, he is the President, Infrastructure Unit and also the Occupier. His responsibilities include safety, health, environment, utilities and engineering procurement.

Mr. Mohanan holds BSc (Engg Hon) degree from the University of Calicut.

Directorship in other companies :

Public Companies:

·         Aasthan Dates Limited - Chairman

·         Atul Biospace Limited - Chairman and Managing Director

·         Atul Clean Energy Limited - Chairman

·         Atul Rajasthan Date Palms Limited - Managing Director

·         Atul Seeds Limited

·         Biyaban Agri Limited - Chairman

·         Raja Dates Limited - Chairman

·         DPD Limited

 

 

Name :

Mr. S Nammalvar

Designation :

Whole-time Director

Date of Birth/ Age :

27.05.1954

Brief Resume :

Mr. S Nammalvar joined the Company in 2011 as President, Technology Unit. His responsibilities include heading technology and manufacturing functions of the Company.

Mr. Nammalvar has over 34 years of experience in various functions and has held leadership positions for over 20 years in companies belonging to Petrochemical, Pharmaceutical and Polymer industries in India and abroad.

Mr. Nammalvar holds ME degree in Chemical Engineering from Annamalai University and Post Graduate Diploma in Business Management from the University of Pune.

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 31.12.2014

 

Category of Shareholder

Total No. of Shares

As a %

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

854316

2.88

http://www.bseindia.com/include/images/clear.gifBodies Corporate

14177219

47.80

http://www.bseindia.com/include/images/clear.gifSub Total

15031535

50.68

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

15031535

50.68

 

 

 

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

3036942

10.24

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

63770

0.21

http://www.bseindia.com/include/images/clear.gifCentral Government / State Government(s)

336

0.00

http://www.bseindia.com/include/images/clear.gifInsurance Companies

498767

1.68

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

1701389

5.74

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

872

0.00

http://www.bseindia.com/include/images/clear.gifTrusts

872

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

5302076

17.88

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

1475737

4.98

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

4783173

16.13

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

2815872

9.49

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

253340

0.85

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

145542

0.49

http://www.bseindia.com/include/images/clear.gifAny Other

88048

0.30

http://www.bseindia.com/include/images/clear.gifOverseas Corporate Bodies

19750

0.07

http://www.bseindia.com/include/images/clear.gifSub Total

9328122

31.45

Total Public shareholding (B)

14630198

49.32

 

 

 

Total (A)+(B)

29661733

100.00

 

 

 

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

 

 

 

Total (A)+(B)+(C)

29661733

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Dyestuff Chemicals, Drugs and Pharmaceuticals.

 

 

Products :

Item Code No.

 

Product Description

3204

Synthetic Organic Colouring Matter

291200

Para Anisic Aldehyde

390730.09

Epoxy Resins

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Available

Name of the Person (Designation):

Not Available

Contact Number:

Not Available

Since how long known:

Not Available

Maximum limit dealt:

Not Available

Experience:

Not Available

Remark

Not Available

 

 

Customers :

Reference:

Not Available

Name of the Person (Designation):

Not Available

Contact Number:

Not Available

Since how long known:

Not Available

Maximum limit dealt:

Not Available

Experience:

Not Available

Remark

Not Available

 

 

No. of Employees :

2761 (Approximately)

 

 

Bankers :

Bank Name:

Not Available

Branch:

Not Available

Person Name (with Designation):

Not Available

Contact Number:

Not Available

Name of Account Holder:

Not Available

Account Number:

Not Available

Account Since (Date/ Year of A/c Opening):

Not Available

Average Balance Maintained (Optional):

Not Available

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Available

Account Operation:

Not Available

Remarks: Not Available

 

·         Axis Bank

·         Bank of Baroda

·         Bank of India

·         Export Import Bank of India

·         State Bank of India

 

 

Facilities :

SECURED LOAN

31.03.2014

Rs. In Million

31.03.2013

Rs. in Million

LONG-TERM BORROWINGS

 

 

Term loans

 

 

Rupee term loans from financial institutions

312.500

416.600

Foreign currency term loans from banks

594.700

696.900

Foreign currency term loans from financial institutions

225.400

430.600

SHORT-TERM BORROWINGS

 

 

Working capital loans repayable on demand from banks

1292.700

1510.900

 

 

 

TOTAL

2425.300

3055.000

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Dalal and Shah

Chartered Accountants

 

 

Cost Auditors

 

Name :

R. Nanabhoy and Company

Cost Accountants

 

 

Subsidiary Companies  :

·         Aasthan Dates Limited

·         Subsidiary companies

·         Ameer Trading Corporation Limited

·         Atul Bioscience Limited

·         Atul Biospace Limited

·         Atul Brasil Quimicos Ltda

·         Atul China Limited

·         Atul Deutschland GmbH

·         Atul Europe Limited

·         Atul Infotech Private Limited

·         Atul Rajasthan Date Palms Limited

·         Atul USA Inc

·         Biyaban Agri Limited

·         DPD Limited

·         Raja Dates Limited

 

 

Joint Venture Company  :

Rudolf Atul Chemicals Limited

 

 

Associate Companies :

·         Amal Limited

·         Anchor Adhesives Private Limited

·         Atul Crop Care Limited

·         LAPOX Polymers Limited

·         M. Dohmen S.A.

·         Atul Elkay Polymers Limited

 

 

Organisations over which significant influence exercised :

·         Welfare funds

·         Atul Club

·         Atul Kelavani Mandal

·         Atul Rural Development Fund

·         Atul Vidyalaya

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

80000000

Equity Shares

Rs. 10/- each

Rs. 800.000 Million

8000000

Cumulative Redeemable Preference Shares

Rs. 100/- each

Rs. 800.000 Million

 

 

 

 

 

Total

 

 

Rs. 1600.000 Million

 

Issued Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

29691780

Equity Shares

Rs. 10/- each

Rs. 296.900 Million

 

 

 

 

 

Subscribed and Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

29661733

Equity Shares

Rs. 10/- each

Rs. 296.600 Million

29991

Add: Forfeited Shares (amount paid up)

 

Rs. 0.200 Million

 

 

 

 

 

Total

 

 

Rs. 296.800 Million

 

a)     Rights, Preferences and restrictions

 

The Company has two classes of Shares referred to as Equity Shares having a par value of Rs.10 and Cumulative Redeemable Preference Shares having a par value of Rs.100.

 

i) Equity Shares:

In the event of liquidation of the Company, the holders of Equity Shares will be entitled to receive any of the remaining assets of the Company, after distribution of all preferential amounts and Preference Shares.

 

The distribution will be in proportion to the number of Equity Shares held by the Shareholders. Each holder of Equity Shares is entitled to one vote per share.

 

ii) Preference Shares:

The Company has Preference Shares having a par value of Rs.100 per share. Each Shareholder is eligible for dividend depending upon their coupon rates. The Preference Shareholder is entitled to one vote per share only on resolutions placed before the Company which directly affect the rights attached to the Preference Shares.

 

iii) Dividend:

The Company declares and pays dividend in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the Shareholders in the ensuing Annual General Meeting.

 

 

b)    Shares reserved for issue at a later date

 

56 Equity Shares are held in abeyance due to disputes at the time of earlier rights issues.

 

 

c)     Details of Shareholders holding more than 5% of Equity Shares:

 

Name of the Shareholders

As at March 31, 2014

 

Holding %

No of shares

Aeon Investments Private Limited*

22.70

6725501

Aura Securities Private Limited

5.44

1614045

Aeon Investments Private Limited

3.50

1039383

 

* During the year certain Promoter group companies were merged. However, there is no change in shareholding of the Promoters due to this merger.

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

296.800

296.800

296.800

(b) Reserves & Surplus

9119.100

7264.100

6122.500

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

9415.900

7560.900

6419.300

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1133.600

1544.300

1449.000

(b) Deferred tax liabilities (Net)

353.900

271.600

223.100

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

51.900

50.400

33.300

Total Non-current Liabilities (3)

1539.400

1866.300

1705.400

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1842.700

1604.500

1935.700

(b) Trade payables

3168.700

2753.200

2778.400

(c) Other current liabilities

1337.300

1129.600

1049.700

(d) Short-term provisions

432.100

360.400

511.400

Total Current Liabilities (4)

6780.800

5847.700

6275.200

 

 

 

 

TOTAL

17736.100

15274.900

14399.900

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

5196.000

4804.500

4175.500

(ii) Intangible Assets

0.000

0.000

2.200

(iii) Capital work-in-progress

529.800

459.300

559.400

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1364.700

1285.600

1250.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

290.600

315.800

281.100

(e) Other Non-current assets

643.100

436.300

347.400

Total Non-Current Assets

8024.200

7301.500

6615.600

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

3757.500

3075.300

2945.700

(c) Trade receivables

4472.600

3616.000

3682.200

(d) Cash and cash equivalents

88.000

78.400

115.200

(e) Short-term loans and advances

1025.400

1034.600

869.400

(f) Other current assets

368.400

169.100

171.800

Total Current Assets

9711.900

7973.400

7784.300

 

 

 

 

TOTAL

17736.100

15274.900

14399.900

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Revenue from operations (net)

23654.500

20014.800

17776.800

 

 

Other Income

396.200

204.600

143.800

 

 

TOTAL                                        (A)

24050.700

20219.400

17920.600

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

13246.000

11270.500

10551.300

 

 

Purchases of Stock-in-Trade

236.900

163.600

200.100

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(664.700)

(0.600)

(153.300)

 

 

Employees benefits expense

1397.900

1276.000

1172.000

 

 

Other expenses

6007.100

4832.700

4002.600

 

 

Exceptional Items

0.000

(53.800)

(65.100)

 

 

Exchange rate difference [net]

0.000

0.000

120.700

 

 

TOTAL                                        (B)

20223.200

17488.400

15828.300

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

3827.500

2731.000

2092.300

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

314.300

316.200

431.000

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

3513.200

2414.800

1661.300

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

542.300

490.600

436.500

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

2970.900

1924.200

1224.800

 

 

 

 

 

Less

TAX                                                                  (H)

843.000

569.000

343.700

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

2127.900

1355.200

881.100

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

10452.600

9290.100

7775.500

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

3871.600

3139.100

3095.400

 

 

Trading finished goods

284.600

109.800

110.300

 

 

Capital Goods

76.800

44.500

54.700

 

TOTAL IMPORTS

4233.000

3293.400

3260.400

 

 

 

 

 

 

Earnings Per Share (Rs.)

71.74

45.69

29.70

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2014

30.09.2014

Type

1st Quarter

2nd Quarter

Net Sales

6470.800

6624.100

Total Expenditure

5432.500

5654.400

PBIDT (Excl OI)

1038.300

969.700

Other Income

15.200

85.600

Operating Profit

1053.500

1055.300

Interest

61.700

57.300

Exceptional Items

0.000

0.000

PBDT

991.800

998.000

Depreciation

135.600

136.700

Profit Before Tax

856.200

861.300

Tax

258.400

270.600

Provisions and contingencies

0.000

0.000

Profit After Tax

597.800

590.700

Extraordinary Items

0.000

0.000

Prior Period Expenses

0.000

0.000

Other Adjustments

0.000

0.000

Net Profit

597.800

590.700

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

9.00

6.77

4.96

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

16.18

13.64

11.77

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

18.75

14.22

9.73

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.32

0.25

0.19

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.32

0.42

0.53

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.43

1.36

1.24

                                                

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

296.800

296.800

296.800

Reserves & Surplus

6122.500

7264.100

9119.100

 Share Application money pending allotment

0.000

0.000

0.000

Net worth

6419.300

7560.900

9415.900

 

 

 

 

long-term borrowings

1449.000

1544.300

1133.600

Short term borrowings

1935.700

1604.500

1842.700

Total borrowings

3384.700

3148.800

2976.300

Debt/Equity ratio

0.527

0.416

0.316

 

 

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

17776.800

20014.800

23654.500

 

 

12.589

18.185

 

 

 

 

NET PROFIT MARGIN

 

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

17776.800

20014.800

23654.500

Profit

881.100

1355.200

2127.900

 

4.96%

6.77%

9.00%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

LITIGATION DETAILS

 

HIGH COURT OF GUJARAT

CIVIL APPLICATION (FOR ORDERS) No. 11985 of 2012

In FIRST APPEAL / 1951 / 2012 (PENDING)

Status: PENDING                        ( Converted from : CAST/12157/2012 )               CCIN No: 001003201211985

 

Last Listing Date: 16/01/2013

 

Coram: - HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA

HONOURABLE MR.JUSTICE J.B.PARDIWALA

 

S.NO.

Name of the Petitioner

Advocate On Record

1
2

JENSON NICHOLSAN INDIA LTD
S P SINHA

MR ADIL R MIRZA for: Petitioner(s) Description: http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1 - 2

S.NO.

Name of the Respondant

Advocate On Record

1

ATUL LIMITED

 

 

Presented On             : 16/10/2012                                                       Registered On              : 17/10/2012

Bench Category         : DIVISION BENCH                                              District                         : VALSAD

Case Originated From: THROUGH HIS/HER/THEIR ADVOCATE  Listed                           : 4 times

Stage Name                : NOTICE & ADJOURNED MATTERS

                                                                                   

Classification

·         DB - CIVIL APPLICATION - CODE OF CIVIL PROCEDURE, 1908 - PRODUCTION OF ADDITIONAL EVIDENCE

  • SJ - CIVIL APPLICATION - CODE OF CIVIL PROCEDURE, 1908 - DELETION OF PARTY

Act

·         CIVIL PROCEDURE CODE, 1908

  • COMPANIES ACT, 1956

 

Office Details

 

S. No

Filing Date

Document Name

Advocate Name

Court Fee on Document

Document Details

1

16/10/2012

APPLICATION

MR ADIL R MIRZA ADVOCATE
for PETITIONER(s) Description: http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png 1

20

MR ADIL R MIRZA:1-2

 

Linked Matters

 

S. No.

Case Detail

Status Name

Disposal Date

Action/Coram

1

FIRST APPEAL/1951/2012

PENDING

-

·         HONOURABLE MR.JUSTICE RAVI R.TRIPATHI 

·         HONOURABLE MR.JUSTICE R.D.KOTHARI

 

Court Proceedings

 

S. No.

Notified Date

CourtCode

Board Sr. No.

Stage

Action

Coram

1

18/10/2012

1

11

OFFICE OBJECTION REMOVED

NEXT DATE

·         HONOURABLE MR.JUSTICE D.H.WAGHELA 

·         HONOURABLE MR.JUSTICE Z.K.SAIYED

2

14/12/2012

1

6

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE MR.JUSTICE D.H.WAGHELA 

·         HONOURABLE MR.JUSTICE G.R.UDHWANI

3

20/12/2012

1

22

FOR REGULAR ADMISSION

NEXT DATE

·         HONOURABLE MR.JUSTICE D.H.WAGHELA 

·         HONOURABLE MR.JUSTICE G.R.UDHWANI

4

16/01/2013

1

18

NOTICE & ADJOURNED MATTERS

NEXT DATE

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

Available Orders

S. No.

Case Details

Judge Name

Order Date

CAV

Judgement

Transferred

Download

1

CIVIL APPLICATION/11985/2012

·         HONOURABLE THE CHIEF JUSTICE MR. BHASKAR BHATTACHARYA 

·         HONOURABLE MR.JUSTICE J.B.PARDIWALA

16/01/2013

N

ORDER

Y

Download

 

 

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10409602

16/03/2013 *

527,700,000.00

STATE BANK OF INDIA

MID CORPORATE GROUP, COMMERCIAL BR., PARAMSIDDHI, 
COMPLEX, ELLISBRIDGE, AHMEDABAD, GUJARAT - 380006 
, INDIA

B71065403

2

10294426

30/07/2011 *

562,500,000.00

INTERNATIONAL FINANCE CORPORATION

MARUTI SUZUKI BUILDING, 3RD FLOOR, PLOT NO. 1, NE 
LSON MANDELA ROAD, VASANT KUNJ, NEW DELHI, DELHI - 
110070, INDIA

B18004713

3

10273656

31/05/2012 *

276,000,000.00

BARCLAYS BANK PLC

FIRST FLOOR, EROS CORPORATE TOWER, NEHRU PLACE, N 
EW DELHI, DELHI - 110019, INDIA

B40839474

4

10090594

25/03/2008 *

781,200,000.00

INTERNATIONAL FINANCE CORPORATION

GODREJ BHAVAN, 3RD FLOOR, MURZBAN ROAD, FORT, MUM 
BAI, MAHARASHTRA - 400001, INDIA

A34455931

5

80026120

03/08/2013 *

4,300,000,000.00

STATE BANK OF INDIA(LEAD BANK OF CONSORTIUM MEMBER 
BANKS)

PARAMSIDDHI, COMMERCIAL BRANCH, OPP V S HOSPITAL, 
ELLISBRIDGE, AHMEDABAD, GUJARAT - 380006, INDIA

B82224783

6

80026296

08/03/1999

150,000,000.00

EXPORT IMPORT BANK OF INDIA

CENTRE ONE, WORLD TRADE CENTRE, CUFFE PARADE, MUM 
BAI, MAHARASHTRA - 400005, INDIA

-

 

* Date of charge modification

 

NOTE

The registered office of the company has been shifted from Ashoka Chambers, Rasala Marg, Eillsbridge, Ahmedabad – 380006, Gujarat, India to the present address.

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

Rs. In Million

31.03.2013

Rs. in Million

LONG TERM BORROWINGS

 

 

Rupee Term Loans from Banks

1.000

0.200

SHORT TERM BORROWINGS

 

 

Loans from Banks Including Foreign Banks

550.000

0.000

Buyer’s credit arrangement

0.000

93.600

 

 

 

Total

 

551.000

93.800

 

 

PERFORMANCE

 

Sales increased by 17% from Rs.19640.000 Million to Rs.2,3070.000 Million aided by both higher volumes (8%) and prices (9%). Sales in India increased by 22% from Rs. 9860.000 Million to Rs.11990.000 Million. Sales outside of India increased by 13% from Rs.9780.000 Million to Rs.11080.000 Million. Revenue from operations increased by 18% from Rs.20010.000 Million to Rs.23650.000 Million. PBT for the year includes about Rs.200.000 Million of one-time special dividend income received; including such special income, the earnings per share increased from Rs.456.900 to Rs.717.400 Million. While the operating profit before working capital changes increased by 38% from Rs.2600.000 Million to Rs.3600.000 Million, the net cash flow from operating activities declined by 16% from Rs.1670.000 Million to Rs.1410.000 Million mainly on account of the growth in working capital consequent to the higher level of sales achieved.

 

Both the Segments of the Company, namely, Life Science Chemicals Segment (LSC) and Performance and Other Chemicals Segment (POC) showed improvement in performance. The sales of LSC increased by 6% from Rs.6990.000 Million to Rs.7380.000 Million, aided by higher sales of Crop Protection and Pharmaceuticals and Intermediates and its EBIT increased by 8% from Rs.1390.000 Million to Rs.1500.000 Million. The sales of POC increased by 24% from to Rs.12650.000 Million Rs.15690.000 Million, supported by growth in Colors and Polymers and its EBIT increased from Rs.900.000 Million to Rs.1730.000 Million.

 

The Company reduced its borrowings (including current maturities on long-term borrowings) by 1% from Rs.3550.000 Million to Rs.3510.000 Million despite the growth in working capital to support higher sales and payments towards capital expenditure of about Rs.1000.000 Million.

 

The Company improved its credit rating from ‘AA-‘ (double A minus) to ‘AA’ (double A) for its long-term borrowings, awarded by CARE. Its rating for short-term borrowings and commercial paper remained at A1+, the highest possible, awarded by CARE.

 

The Company is in the process of implementing 33 projects with a total outlay of about Rs.4800.000 Million; these projects are expected to be commissioned in during 2014-15 and 2015-16. It completed 14 projects related to environment protection during 2013-14 and is expected to complete 8 more projects by way of reduction in and treatment of pollutants.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

BUSINESS-WISE PERFORMANCE

 

CROP PROTECTION

 

Crop Protection Business mainly comprises Fungicides, Herbicides and Insecticides. The products are used by customers belonging to Agriculture industry for the protection of crops. The Business comprises about 15 products and 46 formulations.

 

During 2013-14, sales increased by 12% from Rs. 3850.000 Million to Rs. 4330.000 Million. Sales in India increased by 40% from Rs. 1410.000 Million to Rs. 1970.000 Million; bulk sales in India increased by 38% from Rs. 680.000 Million to Rs. 940.000 Million whereas brand sales which are currently only in India increased by 41% from Rs. 730.000 Million to Rs. 1030.000 Million. Sales outside of India decreased by 3% from Rs. 2440.000 Million to Rs. 2360.000 Million and formed 55% of the total. Growth on account of volume was 10%. Sales from new products and formulations were Rs. 70.000 Million. The Company completed 2 projects and undertook 3 projects for implementation.

 

World market for crop protection chemicals is estimated at US$ 54 bn and is growing at about 3%. Indian market for such chemicals is estimated at US$ 1.5 bn and is growing at about 7%. There are about 60 major companies which dominate the world marketplace, and there are about 13 companies in India having sales of more than US$ 100 mn.

 

The main user industry, namely, Agriculture, is growing well because of increasing population on the one hand and improving standard of living on the other. The Company will participate in this growth by i) building a strong sales and marketing organisation and broadening and deepening its presence in other countries, particularly in Africa and South America, ii) promoting its brands, iii) increasing its manufacturing and working capital efficiencies, iv) generating and adding capacities and v) introducing new products and formulations.

 

Floods or famines will adversely affect the demand. Registration costs are high in certain countries. Fluctuations in foreign exchange may impact sales realizations. Given that some of these chemicals can be toxic, it is essential to take utmost care in their manufacture and use.

 

 

PHARMACEUTICALS

 

Pharmaceuticals and Intermediates Business mainly comprises API intermediates and a few APIs. The products are used by customers belonging to Pharmaceutical industry, under five broad therapeutic categories, namely, anti-depressant, antidiabetic, anti-infective, anti-retroviral and cardiovascular. The Business comprises about 38 products.

 

During 2013-14, sales decreased by 3% from Rs. 3140.000 Million to Rs. 3060.000 Million. Sales in India increased by 1% from Rs. 1710.000 Million to Rs. 1720.000 Million. Sales outside of India decreased by 6% Rs. 1430.000 Million to Rs. 1340.000 Million and formed 44% of the total. Degrowth on account of volume was 7%. Sales from new products were Rs. 70.000 Million. The Company completed 8 projects and undertook 3 projects for implementation. Atul Bioscience Limited, a 100% subsidiary company, focussed on production of advanced API intermediates, sales of which increased by 30% from Rs. 270.000 Million to Rs. 350.000 Million, primarily because of volume; and it completed capacity expansion in both of its plants.

 

World market for pharmaceuticals is estimated at US$ 820 bn (comprising US$ 700 bn prescription drugs and US$ 120 bn generic drugs) and is growing at about 5%. Indian pharmaceuticals market is estimated at US$ 22 bn (including sales out of India) and is growing at about 10%. There are about 20 major companies which dominate the world marketplace in prescription drugs space with share of about 65% and about 8 companies in generic drugs space with share of about 70%.

 

The main user industry, namely, Pharmaceutical, is growing well because of increasing awareness about diseases and health. The Company along with Atul Bioscience will participate in this growth by i) widening its market reach, ii) increasing its manufacturing efficiencies, iii) generating and adding capacities and iv) introducing new products. It will also form long-term alliances with other companies.

 

Prices of many products come down significantly in a short time. Fluctuations in foreign exchange may impact sales realisations.

 

 

AROMATICS

 

Aromatics Business mainly comprises p-Cresol and its downstream products. The products are mainly used by customers belonging to Flavour and Fragrance and Personal Care industries. The Business comprises about 29 products.

 

During 2013-14, sales increased by 6% from Rs. 3880.000 Million to Rs. 4100.000 Million. Sales in India decreased by 10% from Rs. 1130.000 Million to Rs. 1020.000 Million. Sales outside of India increased by 12% from Rs. 2750.000 Million to Rs. 3080.000 Million and formed 75% of the total. Growth on account of volume was 3%. Sales from new products were Rs. 60.000 Million. The Company completed 6 projects and undertook 4 projects for implementation. World market of p-Cresol is estimated at 55,000 mt and is growing at about 3%. Though earlier the product used to be manufactured in the UK and the USA, China and India are now the major suppliers of the product. World market of flavour and fragrance chemicals is estimated at US$ 23 bn and is growing at about 5%.

 

The main user industries, namely, Flavour and Fragrance and Personal Care, are growing well because of increasing population on the one hand and improving standard of living on the other. The Company will participate in this growth by i) broadening its market reach, ii) increasing its manufacturing efficiencies, iii) adding capacities and iv) introducing new products.

 

The prices of key raw materials which are derived from crude oil fluctuate almost monthly whereas the customers in the user industries expect the prices of the finished products to remain firm for a quarter or even more; on such occasions, it is possible to get affected adversely. Fluctuations in foreign exchange may impact sales realisations.

 

 

BULK CHEMICALS AND INTERMEDIATES

 

Bulk Chemicals and Intermediates Business mainly comprises Sodium Hydroxide, Chlorine, Sulphuric Acid, Oleum, Sulphur Trioxide, Chlorosulphonic Acid and Resorcinol. Barring Chlorosulphonic Acid and Resorcinol, the rest of the products are used for captive consumption. Resorcinol is mainly used by customers belonging to Tyre industry. The Business comprises about 26 products.

 

During 2013-14, (external) sales increased by 29% from Rs. 770.000 Million to Rs. 990.000 Million. Sales in India increased by 37% from Rs. 600.000 Million to Rs. 820.000 Million. Sales outside of India remained constant at Rs. 170.000 Million and formed 17% of the total. Growth on account of volume was 16%. Sales from new products were Rs. 190.000 Million. The Company completed 1 project and undertook 2 projects for implementation.

 

World market for bulk chemicals is growing at about 0.5% and Indian market is growing at about 2%. World market for Resorcinol is estimated at US$ 300 mn and is growing at about 3%; Indian market for the product is estimated at US$ 15 mn and is growing at about 5%.

 

The captive consumption of bulk chemicals is expected to grow as the Company expands manufacturing capacities of its various products. Tyre industry is expected to grow further because of increasing population on the one hand and improving standard of living on the other. The Company will participate in this growth by i) widening its market reach, ii) increasing its manufacturing efficiencies, iii) modernising its bulk chemicals plant, iv) adding capacities and v) introducing new and downstream products.

 

The demand and prices of bulk chemicals are cyclical in nature. Fluctuations in foreign exchange may impact sales realisations.

 

 

COLORS

 

Colors Business mainly comprises dyes for natural fibres such as Vat, Sulphur Black and Reactive and in a small way high performance pigments. The products are used by customers belonging to Textile and Paint and Coatings industries. The Business comprises about 550 products. Rudolf Atul Chemicals Limited, a JV company formed in 2011-12, provides a complete range of textile chemicals in Indian market.

 

During 2013-14, sales increased by 29% from Rs. 3300.000 Million to Rs. 4260.000 Million. Sales in India increased by 24% from Rs. 1870.000 Million to Rs. 2310.000 Million. Sales outside of India increased by 36% from Rs. 1430.000 Million to Rs. 1950.000 Million and formed 46% of the total. Increase on account of volume was 6%. Sales from new products were Rs. 300.000 Million. The Company completed 5 projects and undertook 4 projects for implementation. It sold off its shareholding in M. Dohmen S.A., a JV company; the transaction was however completed on April 03, 2014. Rudolf Atul Chemicals increased sales by 51% from Rs. 210.000 Million to Rs. 310.000 Million, mainly because of volume growth.

 

World market for dyes and textile chemicals is estimated at US$ 12 bn and is growing at about 2% and Indian market is estimated at US$ 800 mn and is growing at about 3%. China is the largest manufacturer of dyes followed by India. World market for high performance pigments is estimated at US$ 3.5 bn and is growing at about 4%.

 

The main user industry, namely, Textile, is showing signs of recovery in India and abroad. Automobile industry is growing well. The Company along with Rudolf Atul Chemicals will participate in this growth by i) broadening its market reach, ii) increasing its manufacturing and working capital efficiencies and iii) introducing new dyes, pigments and textile chemicals.

 

Fluctuations in foreign exchange may impact sales realisations. Treatment costs are expected to remain high given that the manufacture of dyes generates significant pollutants.

 

 

POLYMERS

 

Polymers Business mainly comprises Epoxy Resins and Hardeners and formulations thereof, other components such as air release agents, reactive diluents, rheological modifiers, wetting agents, etc and Sulphones. These products are used by Automobile, Construction, Defence, Electrical and Electronics, Footwear, Handicraft, Marine, Paint and Coatings, Paper and Wind Energy industries. The Business comprises about 64 products and 275 formulations.

 

During 2013-14, sales increased by 35% from Rs. 4680.000 Million to Rs. 6330.000 Million. Sales in India increased by 33% from Rs. 3120.000 Million to Rs. 4150.000 Million. Brand sales which is currently only in India increased by 18% from Rs. 720.000 Million from to Rs. 850.000 Million. Sales outside of India increased by 40% from Rs. 1560.000 Million to Rs. 2180.000 Million and formed 34% of the total. Increase on account of volume was 24%. Sales from new products were Rs. 120.000 Million. The Company completed 4 projects and undertook 5 projects for implementation. Though already incorporated, Atul Elkay Polymers Limited, a JV company, is still assessing the demand potential for stone care chemicals in India.

 

World market for Epoxy Resins and Hardeners is estimated at US$ 6.2 bn and is growing at about 2% and Indian market is estimated at US$ 225 mn and is growing at about 5%. There are about 7 major companies which dominate the world marketplace. The two key raw materials, namely Bisphenol-A and Epichlorohydrin, are imported into India. World market for Sulphones is estimated at US$ 300 mn and is growing at about 4%.

 

The user industries, Construction, Defence, Electrical and Electronics and Paint and Coatings, are growing well, particularly in India. The Company will participate in this growth by i) widening its market reach, ii) increasing its manufacturing and working capital efficiencies, iii) generating and adding new capacities of Epoxy Resins and Hardeners and iv) introducing new products and formulations.

 

Cheaper imports of Epoxy Resins and Hardeners will keep the contribution margins under pressure. Since the two main raw materials are imported, fluctuations in foreign exchange may impact margins.

 

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

Claims against the Company not acknowledged as debts in respects of:

 

 

(a) Excise

72.100

58.400

(b) Income tax

281.000

350.300

(c) Sales tax

6.700

0.000

(d) Customs

27.800

27.800

(e) Water charges

770.300

719.200

(f) Others

146.400

135.400

 

 

 

Total

 

1304.300

1291.100

 

NOTE: Future cash outflows in respect of (a) to (f) above are determinable on receipt of judgements | decisions pending with various forums | authorities

 

 

 

FIXED ASSETS:

 

·         Land – Freehold

·         Buildings

·         Roads

·         Plant and Equipment

·         Railway Siding

·         Office Equipment and Furniture

·         Vehicles

·         Computer software

 

 

STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31.12.2014

 

(RS. IN MILLION)

 

PARTICULARS

Quarter Ended

Nine Months Ended

 

31.12.2014

[Unaudited]

30.09.2014

[Unaudited]

31.12.2014

[Unaudited]

Income from Operations

 

 

 

Net Sales/Income from Operations

6171.800

6512.400

19046.100

Other Operating Income

99.400

111.700

320.000

Total Income from operations (net)

6271.200

6624.100

19366.100

 

 

 

 

Expenses

 

 

 

(a) Cost of material consumed 

3247.700

3618.100

10406.800

(b) Purchase of stock in trade

61.400

84.100

223.800

(c) Changes in inventories of finished goods, work in progress and stock in trade

27.000

(52.500)

(85.300)

(d) Power, fuel and water

734.600

751.400

2209.600

(e) Employee benefit expenses

387.700

383.600

1172.000

(f) Depreciation and amortization expenses

138.500

136.700

410.800

(g) Other Expenses

870.700

869.700

2489.100

Total Expenses

5467.600

5791.100

16826.800

Profit from Operations before Other Income, Finance costs

803.600

833.000

2539.300

Other Income

38.600

85.600

139.400

Profit/ Loss from Ordinary Activities before Finance costs

842.200

918.600

2678.700

Finance costs

62.500

57.300

181.500

Profit/ Loss from Ordinary Activities before tax

779.700

861.300

2497.200

Tax Expenses

 

 

 

- Current Tax

215.00

235.000

698.700

- Deferred Tax

27.600

35.600

72.900

Net Profit/ Loss from Ordinary Activities after tax

537.100

590.700

1725.600

Paid- up Equity Share Capital (Face value of the share – Rs. 10)

296.600

296.600

 

Reserves excluding revaluation reserves as per balance sheet of Previous Accounting Year

--

--

--

Earnings Per Share

 

 

 

Basic and Diluted

18.11

19.92

58.18

 

 

 

 

PARTICULARS OF SHAREHOLDING

 

 

 

1. Public shareholding

 

 

 

Number of Shares

14630198

14639571

14630198

Percentage of Shareholding

49.32%

49.36%

49.32%

2. Promoters and promoter group shareholding

 

 

 

a) Pledged/Encumbered

 

 

 

- Number of Shares

430000

430000

430000

- Percentage of Shares (as a % of the Total Shareholding of promoter and promoter group)

2.86%

2.86%

2.86%

- Percentage of Shares (as a % of the Total Share Capital of the Company)

1.45%

1.45%

1.45%

 

 

 

 

Non - encumbered

 

 

 

- Number of Shares

14601535

14592162

14601535

- Percentage of Shares

(as a % of the total shareholding of promoter and promoter group)

97.14%

97.14%

97.14%

- Percentage of Shares

(as a % of the total share capital of the company)

49.23%

49.19%

49.23%

 

 

 

PARTICULARS

Quarter Ended 31.12.2014

B

Investor complaints (Nos.)

 

 

Pending at the beginning of the quarter

Nil

 

Received during the quarter

5

 

Disposed of during the quarter

5

 

Remaining unresolved at the end of the quarter

Nil

 

 

SEGMENT REVENUE, RESULTS AND CAPITAL EMPLOYED

 

(RS. IN MILLION)

 

PARTICULARS

Quarter Ended

Nine Months Ended

 

31.12.2014

[Unaudited]

30.09.2014

[Unaudited]

31.12.2014

[Unaudited]

1. Segment Revenue

 

 

 

a. Life Science Chemicals 

1683.800

1790.300

5247.000

b. Performance and Other Chemicals 

4968.800

5198.800

15136.600

Total

652.600

6989.100

20383.600

Less: Inter – segment revenue

480.800

476.700

1337.500

Total income from operations (net)

6171.800

6512.400

19046.100

 

 

 

 

2. Segment Results

 

 

 

Profit/ (loss) before tax and interest

 

 

 

a. Life Science Chemicals 

280.700

297.100

949.600

b. Performance and Other Chemicals 

594.300

649.100

1848.600

Total

875.000

946.200

2798.200

Less: Finance Costs

62.500

57.300

181.500

Other un-allocable expenditure net off un-allocable other operating income

32.800

27.600

119.500

Total Profit Before Tax

779.700

861.300

2497.200

 

 

 

 

3. Capital Employed

 

 

 

(Segment Assets – Segment Liabilities)

 

 

 

a. Life Science Chemicals 

3465.900

3314.100

3465.900

b. Performance and Other Chemicals 

7503.700

7014.100

7503.700

c. Unallocated

1890.300

2297.700

1890.300

Total

12859.900

12625.900

12859.900

 

NOTE :

 

1. The above results have been reviewed and recommended for adoption by the Audit Committee at its meeting held on January 22, 2015 and approved by the Board of Directors at its meeting held on January 23, 2015.

 

2. The Board of Directors ("The Board") approved the Draft scheme of merger ("The scheme") of Amal Ltd with the Company on December 05, 2014. The Board has approved a share swap ratio of 1 equity share of the face value of Rs. 10 each fully paid up of Atul Ltd for every 50 equity shares of the face value of Rs. 10 each fully paid up of Amal Ltd. The scheme shall be subject to appropriate statutory and regulatory approvals. Pending such approvals, effect of the scheme is not given in the above results.

 

3. 'Other income' for the quarter / nine months ended December 31, 2013 included a one time special dividend of Rs. 198.600 Million.

 

4. The Company had reversed the revaluation reserve of Rs. 1013.800 Million, during the quarter / half year ended September 30, 2014.

 

5. Figures of the earlier periods have been regrouped / recast / reclassified wherever necessary including in the Segment revenue, results and capital employed.

 

6. The Auditors of the Company have carried out a Limited Review of the above financial results and their report contains no qualification.

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.59

UK Pound

1

Rs. 92.46

Euro

1

Rs. 67.51

 

 

INFORMATION DETAILS

 

Information gathered by :

SVA

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

SNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.